Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T lymphocyte and B lymphocyte are two distinct subtypes of lymphocytes, a major class of white blood cells fundamental to the adaptive immune system[3][4][5][7][8]. - **T lymphocytes** are primarily responsible for cell-mediated immunity, recognizing and destroying infected or abnormal cells and orchestrating immune responses via cytokine release and helper functions[6][7]. - **B lymphocytes** mediate humoral immunity through production and secretion of antibodies, serving as precursors to plasma cells and memory B cells[1][8]. Both cell types express specific antigen receptors (TCR for T cells, BCR for B cells), are central to immune memory, and participate in nearly all aspects of adaptive immune defense, as well as many immune-mediated diseases[2][3][4][5][6][7][8]. Dysfunction or therapeutic modulation of these cells underlies numerous infectious, malignant, and immune-mediated conditions. Note: If you are seeking information about a specific therapeutic target, such as "CD20" (on B cells) or "PD-1" (on T cells), it is preferable to specify the precise molecule or receptor rather than the entire cell type. The entry "T lymphocytes and B lymphocytes" is not a standard pharmacological or molecular target, but classes of immune cells with diverse roles and many interacting surface molecules[3][4][8].
Modulation or depletion of cell population (e.g., anti-CD20 monoclonal antibodies deplete B cells) Activation/inhibition of receptors (e.g., PD-1/PD-L1 blockade reactivates T cells) Immune suppression (e.g., calcineurin inhibitors suppress T cell activation) Adoptive cell transfer (infusion of engineered T cells)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T lymphocyte and B lymphocyte (T cell and B cell).